Home NAFDAC NAFDAC expresses concern over prevalence of substandard drugs

NAFDAC expresses concern over prevalence of substandard drugs

2 min read
0
0
42

The Director-General (DG) of the National Agency for Food Drugs Administration and Control (NAFDAC) Prof Mojisola Adeyeye, on Thursday, expressed concern over the high level of fake, substandard and falsified drugs in the country.

She stated this during a one-day sensitisation campaign programme, held in Ibadan, the Oyo State capital.

Adeyeye, who was represented by the Zonal Director of the agency, Roselyn Ajayi, revealed that the agency will pay advocacy visits to churches, mosques, traditional rulers and opinion leaders on how to avoid patronising people who sell unwholesome and fake products.

He said, “Our survey has shown that the level of prevalence of substandard and falsified products is high across the nation.

“The outcome of such a survey necessitated the need for sensitisation and engagement of the healthcare providers to interact on how the prevalence of substandard and falsified medicine can be reduced.

“From the experiences and survey report, it was observed that fakers and counterfeiters are getting smarter and faster taking advantage of the possibilities and opportunities of advancement in technology, hence the sensitisation and campaign programme”.

In his remarks, the Chairman of the Oyo State Association of Community Pharmacists of Nigeria, Adebayo Gbadamosi, appealed to citizens to always patronise registered pharmacists and avoid quacks.

“Some of these drugs also have scratches. You can scratch to know the authenticity of the drugs. If our people are informed and they stop buying fake drugs, it will discourage the quacks”, he said.

Load More Related Articles
Load More By Breezynews
Load More In NAFDAC

Leave a Reply

Your email address will not be published. Required fields are marked *

Check Also

2024 budget implementation to extend to June 2025 – Akpabio

Senate President Godswill Akpabio has said that the implementation of the 2024 Appropriati…